Inhibiting interferon-γ induced cancer intrinsic TNFRSF14 elevation restrains the malignant progression of glioblastoma.
Yunhe HanCunyi ZouTianqi LiuWen ChengPeng ChengAn-Hua WuPublished in: Journal of experimental & clinical cancer research : CR (2024)
Our findings highlight a malignant TNFRSF14/FAK axis as a potential target to blunt cancer-intrinsic resistance to ICB treatment, which may help improve the therapeutic efficiency of immunotherapy in malignancies.